GLP-1 agonists cause gastrointestinal side effects including nausea, reduced appetite, and altered motility
The key to success in peptide therapy is not just the compound you choose, but the precision and consistency of your dosing
Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters
(n.d.-c)
5-Amino-1MQ reduces NNMT, improving NAD+ retention, metabolism, and fat reduction in models.[4][5] Mouse studies demonstrate obesity reversal and muscle enhancement
While a single Vitamin B12 injection can provide immediate benefits, regular injections are often necessary to maintain these positive effects
